DongKook Pharmaceutical Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	58,694	56,179	50,272	60,552	73,693	85,444
Short-Term Investments	53,759	62,410	40,582	33,608	29,512	83,439
Trading Asset Securities	5,908	8,513	-	-	3,899	1,047
Cash & Short-Term Investments	118,361	127,102	90,854	94,160	107,105	169,929
Cash Growth	1.92%	39.90%	-3.51%	-12.09%	-36.97%	-3.61%
Accounts Receivable	231,149	222,159	180,595	161,107	134,072	123,949
Other Receivables	19,081	22,409	22,000	17,779	17,361	14,046
Receivables	256,945	251,284	209,389	179,061	151,600	139,299
Inventory	183,336	175,249	159,577	138,343	120,152	102,591
Prepaid Expenses	5,579	5,623	4,639	4,058	2,629	3,949
Other Current Assets	7,505	6,138	5,547	3,575	3,836	4,457
Total Current Assets	571,725	565,396	470,007	419,197	385,321	420,226
Property, Plant & Equipment	326,787	312,222	299,459	272,705	263,355	234,941
Long-Term Investments	129,227	120,943	119,662	108,300	87,892	71,363
Goodwill	12,172	12,172	12,172	-	-	-
Other Intangible Assets	20,390	20,234	19,733	8,537	8,202	6,916
Long-Term Accounts Receivable	-	-	-0	-	-	-
Long-Term Deferred Tax Assets	5,357	3,249	1,892	1,702	1,695	1,970
Long-Term Deferred Charges	9,934	9,814	10,594	7,626	2,672	-
Other Long-Term Assets	15,749	18,854	19,646	15,466	13,191	8,655
Total Assets	1,091,353	1,062,896	953,165	839,535	768,330	750,076
Accounts Payable	117,265	105,676	80,351	62,069	33,405	29,171
Accrued Expenses	5,221	4,345	4,212	3,624	2,754	3,603
Short-Term Debt	22,774	32,874	46,744	48,228	36,954	82,191
Current Portion of Long-Term Debt	18,717	19,217	2,227	5,729	-	-
Current Portion of Leases	4,972	3,294	3,089	2,528	1,954	2,044
Current Income Taxes Payable	14,179	14,480	14,085	4,949	10,293	6,758
Current Unearned Revenue	184.01	38.12	416.12	0.95	0.86	0.78
Other Current Liabilities	94,833	87,490	81,568	75,982	88,153	96,501
Total Current Liabilities	278,145	267,414	232,692	203,111	173,514	220,269
Long-Term Debt	15,588	15,687	22,904	18,750	25,000	10,000
Long-Term Leases	5,929	5,167	5,723	1,469	2,449	3,687
Long-Term Deferred Tax Liabilities	3,522	3,553	6,505	4,846	4,806	5,765
Other Long-Term Liabilities	7,567	7,337	6,364	7,144	6,471	6,378
Total Liabilities	310,750	299,158	274,189	235,319	212,241	246,099
Common Stock	22,615	22,615	22,230	22,230	22,230	22,230
Additional Paid-In Capital	27,809	28,020	24,800	16,944	14,371	14,459
Retained Earnings	628,714	612,970	558,208	507,318	467,179	419,761
Treasury Stock	-734.15	-734.15	-3,016	-3,053	-3,095	-3,138
Comprehensive Income & Other	869.51	869.51	869.51	869.51	869.51	869.51
Total Common Equity	679,273	663,741	603,092	544,309	501,554	454,181
Minority Interest	101,330	99,997	75,499	31,480	29,125	27,079
Shareholders' Equity	780,603	763,739	678,976	604,216	556,089	503,977
Total Liabilities & Equity	1,091,353	1,062,896	953,165	839,535	768,330	750,076
Total Debt	67,980	76,240	80,687	76,704	66,357	97,922
Net Cash (Debt)	50,381	50,862	10,167	17,456	40,748	72,008
Net Cash Growth	32.29%	400.27%	-41.76%	-57.16%	-43.41%	-33.18%
Net Cash Per Share	1122.31	1136.38	227.26	390.25	911.09	1610.23
Filing Date Shares Outstanding	45.12	45.11	43.97	43.96	43.96	43.95
Total Common Shares Outstanding	45.12	45.11	43.97	43.96	43.96	43.95
Working Capital	293,580	297,982	237,315	216,087	211,807	199,957
Book Value Per Share	15056.19	14713.60	13716.51	12381.26	11410.55	10334.43
Tangible Book Value	646,712	631,336	571,187	535,772	493,352	447,265
Tangible Book Value Per Share	14334.46	13995.25	12990.87	12187.07	11223.95	10177.07
Land	109,815	107,419	114,638	102,959	107,234	91,415
Buildings	136,712	131,193	132,740	114,323	82,855	56,325
Machinery	266,495	261,503	239,876	211,538	172,505	158,211
Construction In Progress	40,357	30,862	9,257	7,535	46,091	57,785